William Hill to Receptor for Advanced Glycation End Products
This is a "connection" page, showing publications William Hill has written about Receptor for Advanced Glycation End Products.
Connection Strength
0.051
-
An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Med. 2012 Jun; 14(2):119-30.
Score: 0.024
-
Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging. 2004 Sep; 25(8):1023-32.
Score: 0.014
-
Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites. J Mol Neurosci. 2003; 20(3):223-32.
Score: 0.013